AbbVie and Tentarix enter biologic development deal

AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and develop biologic candidates in oncology and immunology.

Related Posts

Novartis signs deal for Arvinas’ prostate cancer therapy

Apr 13, 2024

China grants EUA to Covid-19 vaccine against XBB descen...

Jun 9, 2023

NexImmune to lay off over half of its employees

Sep 1, 2023